A Phase 1, Placebo-Controlled, Randomized Study To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Following Single, Escalating, Intravenous Doses Of RN316 In Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 07 Nov 2012
At a glance
- Drugs Bococizumab (Primary)
- Indications Hypercholesterolaemia
- Focus Adverse reactions
- 07 Nov 2012 Pooled analysis presented at the 85th Annual Scientific Sessions of the American Heart Association.
- 03 Jul 2012 Official Title amended as reported by ClinicalTrials.gov.
- 18 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.